Telomerase Biology Associations Offer Keys to Cancer and Aging Therapeutics

Author:

Smith-Sonneborn Joan1

Affiliation:

1. Department Zoology and Physiology, University of Wyoming, Laramie, Wyoming, WY, United States

Abstract

Background: Although telomerase has potential for age-related disease intervention, the overexpression of telomerase in about 90% of cancers, and in HIV virus reservoirs, cautions against se in anti-aging telomerase therapeutics. While multiple reviews document the canonical function of telomerase for maintenance of telomeres, as well as an increasing numbers of reviews that reveal new non-canonical functions of telomerase, there was no systematic review that focuses on the array of associates of the subunit of Telomerase Reverse transcriptase protein (TERT) as pieces of the puzzle to assemble a picture of the how specific TERT complexes uniquely impact aging and age-related diseases and more can be expected. Methods: A structured search of bibliographic data on TERT complexes was undertaken using databases from the National Center for Biotechnology Information Pubmed with extensive access to biomedical and genomic information in order to obtain a unique documented and cited overview of TERT complexes that may uniquely impact aging and age-related diseases. Results: The TERT associations include proper folding, intracellular TERT transport, metabolism, mitochondrial ROS (Reactive Oxygen Species) regulation, inflammation, cell division, cell death, and gene expression, in addition to the well-known telomere maintenance. While increase of cell cycle inhibitors promote aging, in cancer, the cell cycle check-point regulators are ambushed in favor of cell proliferation, while cytoplasmic TERT protects a cell cycle inhibitor in oxidative stress. The oncogene cMyc regulates gene expression for overexpression of TERT, and reduction of cell cycle inhibitors-the perfect storm for cancer promotion. TERT binds with the oncogene RMRP RNA, and TERT-RMRP function can regulate levels of that oncogene RNA, and TERT in a TBN complex can regulate heterochromatin. Telomerase benefit and novel function in neurology and cardiology studies open new anti- aging hope. GV1001, a 16 amino acid peptide of TERT that associates with Heat Shock Proteins (HSP’s), bypasses the cell membrane with remarkable anti disease potential. Conclusions: TERT “associates” are anti-cancer targets for downregulation, but upregulation in antiaging therapy. The overview revealed that unique TERT associations that impact all seven pillars of aging identified by the Trans-NIH Geroscience Initiative that influence aging and urge research for appropriate targeted telomerase supplements/ stimulation, and inclusion in National Institute on Aging Intervention Testing Program. The preference for use of available “smart drugs”, targeted to only cancer, not off-target anti- aging telomerase is implied by the multiplicity of TERT associates functions.

Publisher

Bentham Science Publishers Ltd.

Subject

General Medicine

Reference144 articles.

1. Huang D.S.; Wang Z.; He X.J.; Diplas B.H.; Yang R.; Killela P.J.; Meng Q.; Ye Z.Y.; Wang W.; Jiang X.T.; Xu L.; He X.L.; Zhao Z.S.; Xu W.J.; Wang H.J.; Ma Y.Y.; Xia Y.J.; Li L.; Zhang R.X.; Jin T.; Zhao Z.K.; Xu J.; Yu S.; Wu F.; Liang J.; Wang S.; Jiao Y.; Yan H.; Tao H.Q.; Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation. Eur J Cancer 2015,51(8),969-976

2. Chiba K.; Lorbeer F.K.; Shain A.H.; McSwiggen D.T.; Schruf E.; Oh A.; Ryu J.; Darzacq X.; Bastian B.C.; Hockemeyer D.; Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism. Science 2017,357(6358),1416-1420

3. Heidenreich B.; Kumar R.; TERT promoter mutations in telomere biology. Mutat Res 2017,771,15-31

4. Lee D.D.; Leão R.; Komosa M.; Gallo M.; Zhang C.H.; Lipman T.; Remke M.; Heidari A.; Nunes N.M.; Apolónio J.D.; Price A.J.; De Mello R.A.; Dias J.S.; Huntsman D.; Hermanns T.; Wild P.J.; Vanner R.; Zadeh G.; Karamchandani J.; Das S.; Taylor M.D.; Hawkins C.E.; Wasserman J.D.; Figueiredo A.; Hamilton R.J.; Minden M.D.; Wani K.; Diplas B.; Yan H.; Aldape K.; Akbari M.R.; Danesh A.; Pugh T.J.; Dirks P.B.; Castelo-Branco P.; Tabori U.; DNA hypermethylation within TERT promoter upregulates TERT expression in cancer. J Clin Invest 2019,129(1),223-229

5. Lewis K.A.; Tollefsbol T.O.; Regulation of the telomerase reverse transcriptase subunit through epigenetic mechanisms. Front Genet 2016,7,83

Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3